Year: 2025

This New York skyscraper had a 1-in-16 chance of collapse. Only one man knew

A New York skyscraper’s deadly 1-in-16 collapse odds—revealed by one man

The story of the Citicorp Center skyscraper, a New York landmark with a hidden and near-fatal design flaw, serves as a powerful testament to the critical role of human integrity and expertise in the world of engineering. For decades, the public was unaware that one of the city’s most recognizable buildings was, in fact, an impending catastrophe waiting for the right storm to strike. This chilling secret was known by only one person, an engineer whose unwavering ethical compass ultimately saved countless lives. The narrative is a compelling blend of design hubris, mathematical precision, and the quiet heroism of a…
Read More
Intel shares jump after report of possible US stake in chipmaker

Intel shares soar as US eyes possible investment in chipmaker

Reports that the United States government may be considering an equity stake in Intel have led to a significant surge in the chipmaker's stock value. This development, if it were to materialize, would represent a major and unconventional form of federal intervention in the semiconductor industry. The speculation has been fueled by a new, more direct approach to supporting domestic technology leaders, particularly as the U.S. seeks to bolster its supply chain resilience and national security in a fiercely competitive global landscape. It suggests a potential shift from simple grants and loans to a more intertwined public-private partnership, with the…
Read More
FDA warns about unapproved thyroid pills — then says it'll 'ensure access' to them

FDA flags unapproved thyroid pills — but says it will ‘ensure access’ to them

The recent declaration from the Food and Drug Administration (FDA) concerning non-approved thyroid treatments has led to a complicated and sometimes inconsistent scenario for both patients and medical professionals. The agency has issued a significant alert about the potential safety hazards linked to these medications, particularly a type of "animal-derived thyroid" (ADT) products. At the same time, the FDA has expressed its plan to "maintain accessibility" to these exact medications, at least for a temporary phase. This dual communication highlights the fragile equilibrium the FDA must maintain between its duty to safeguard public health and its obligation to avoid disrupting…
Read More
Will AI make language dubbing easy for film and TV?

Will AI make film and TV language dubbing more efficient?

The emergence of artificial intelligence is set to significantly transform the field of media localization, especially in the area of dubbing for movies and television. For many years, the task of converting and re-recording dialogues for international audiences has been a time-consuming and costly effort, relying on a network of human translators, voice artists, and sound engineers. AI technologies now offer the prospect of a new model, where the constraints of time, expense, and accessibility are considerably minimized. This change could make content distribution more accessible, enabling creators of all sizes to reach audiences globally, but it also raises complex…
Read More